203 related articles for article (PubMed ID: 29154041)
1. Patient Characteristics, Treatment Patterns and Prognostic Factors in Squamous Cell Bladder Cancer.
Zahoor H; Elson P; Stephenson A; Haber GP; Kaouk J; Fergany A; Lee B; Koshkin V; Ornstein M; Gilligan T; Garcia JA; Rini B; Grivas P
Clin Genitourin Cancer; 2018 Apr; 16(2):e437-e442. PubMed ID: 29154041
[TBL] [Abstract][Full Text] [Related]
2. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience.
Kassouf W; Spiess PE; Siefker-Radtke A; Swanson D; Grossman HB; Kamat AM; Munsell MF; Guo CC; Czerniak BA; Dinney CP
Cancer; 2007 Aug; 110(4):764-9. PubMed ID: 17614317
[TBL] [Abstract][Full Text] [Related]
3. Lymphovascular invasion is associated with oncologic outcomes following radical cystectomy for squamous cell carcinoma of the urinary bladder.
Spradling K; Lotan Y; Shokeir A; Abol-Enein H; Mosbah A; Morgan JB; Ghoneim M; Youssef RF
Urol Oncol; 2016 Sep; 34(9):417.e1-8. PubMed ID: 27157247
[TBL] [Abstract][Full Text] [Related]
4. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
[TBL] [Abstract][Full Text] [Related]
5. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience.
Choong NW; Quevedo JF; Kaur JS
Cancer; 2005 Mar; 103(6):1172-8. PubMed ID: 15700264
[TBL] [Abstract][Full Text] [Related]
6. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
[TBL] [Abstract][Full Text] [Related]
7. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
8. Oncologic Outcomes of Squamous Cell Carcinoma Versus Urothelial Carcinoma With Squamous Differentiation After Radical Cystectomy for Bladder Carcinoma.
Laymon M; Mosbah A; Hashem A; Mahmoud O; Harraz AM; Elsawy AA; Abol-Enein H
Clin Genitourin Cancer; 2022 Apr; 20(2):148-154. PubMed ID: 34998698
[TBL] [Abstract][Full Text] [Related]
9. Is survival after radical cystectomy for bladder cancer in Saudi patients different from that of Western patients?
Mokhtar A; Al MM; Al WM; Othman KA; Kattan SA; Al MF
Ann Saudi Med; 2017; 37(3):194-200. PubMed ID: 28578357
[TBL] [Abstract][Full Text] [Related]
10. Impact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy.
Tabata M; Ikeda M; Urakami S; Takahashi S; Sakaguchi K; Kurosawa K; Okaneya T
Jpn J Clin Oncol; 2015 Oct; 45(10):963-7. PubMed ID: 26130451
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation.
Zargar-Shoshtari K; Sverrisson EF; Sharma P; Gupta S; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ
Clin Genitourin Cancer; 2016 Feb; 14(1):82-8. PubMed ID: 26411593
[TBL] [Abstract][Full Text] [Related]
12. Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time.
Ploussard G; Shariat SF; Dragomir A; Kluth LA; Xylinas E; Masson-Lecomte A; Rieken M; Rink M; Matsumoto K; Kikuchi E; Klatte T; Boorjian SA; Lotan Y; Roghmann F; Fairey AS; Fradet Y; Black PC; Rendon R; Izawa J; Kassouf W
Eur Urol; 2014 Aug; 66(2):361-70. PubMed ID: 24139235
[TBL] [Abstract][Full Text] [Related]
13. P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
Kassouf W; Spiess PE; Brown GA; Munsell MF; Grossman HB; Siefker-Radtke A; Dinney CP; Kamat AM
Eur Urol; 2007 Sep; 52(3):769-74. PubMed ID: 17434254
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma.
Pokuri VK; Syed JR; Yang Z; Field EP; Cyriac S; Pili R; Levine EG; Azabdaftari G; Trump DL; Guru K; George S
Clin Genitourin Cancer; 2016 Feb; 14(1):e59-65. PubMed ID: 26508364
[TBL] [Abstract][Full Text] [Related]
15. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
[TBL] [Abstract][Full Text] [Related]
16. Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy.
Kassouf W; Agarwal PK; Grossman HB; Leibovici D; Munsell MF; Siefker-Radtke A; Pisters LL; Swanson DA; Dinney CP; Kamat AM
Urology; 2009 Jan; 73(1):147-52. PubMed ID: 18848348
[TBL] [Abstract][Full Text] [Related]
17. Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy.
Zargar-Shoshtari K; Kongnyuy M; Sharma P; Fishman MN; Gilbert SM; Poch MA; Pow-Sang JM; Spiess PE; Zhang J; Sexton WJ
World J Urol; 2016 Nov; 34(11):1567-1573. PubMed ID: 27072536
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of the Memorial Sloan Kettering Cancer Center nomogram in the prognosis of patients treated with radical cystectomy for invasive bladder cancer.
Molina Escudero R; Herranz Amo F; Monzo Gardiner J; Paez Borda A; Hernandez Fernandez C
Arch Esp Urol; 2013 Nov; 66(9):859-64. PubMed ID: 24231296
[TBL] [Abstract][Full Text] [Related]
19. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer.
Mitra AP; Skinner EC; Miranda G; Daneshmand S
BJU Int; 2013 Feb; 111(2):240-8. PubMed ID: 22928881
[TBL] [Abstract][Full Text] [Related]
20. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.
Bhindi B; Frank I; Mason RJ; Tarrell RF; Thapa P; Cheville JC; Costello BA; Pagliaro LC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA
Eur Urol; 2017 Nov; 72(5):660-664. PubMed ID: 28545841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
